Search - tctmd.com

Displaying 841 - 860 of 925

Sort: Relevancy | Date

News Conference News

Landmark Analyses Show Downside of Prolonged Antiplatelet Therapy

September 02, 2011

News Conference News

Long-term Antiplatelet Therapy: All Risk, No Benefit

August 30, 2011

News Conference News

New-Generation DES Reduce Restenosis, Stent Thrombosis

August 29, 2011

News Daily News

TRIAS HR Published: Genous Stent Doubles Target Lesion Failure

Leah Lawrence

August 23, 2011

News Industry News

First Patient in Japan Treated with Abbott's Bioresorbable Vascular Scaffold as Part of Global Clinical Trial

August 16, 2011

News Daily News

Selective Use of DES Saves Millions of Dollars a Year

Jason Kahn

August 15, 2011

News Daily News

Angioplasty May Be Alternative to Surgery for Common Femoral Artery Disease

Jason Kahn

August 08, 2011

News Industry News

Micell Technologies Completes Enrollment in DESSOLVE II Study of the MiStent® Drug-Eluting Coronary Stent

July 26, 2011

News Industry News

Medtronic Resolute® Drug-Eluting Stent Shows Superiority to Taxus® DES in Study of Patients with Coronary Artery Disease

July 26, 2011

News Industry News

InspireMD Enrolls First Patient in the MASTER (MGuard for Acute ST Elevation Reperfusion) Randomized Trial

July 26, 2011

News Industry News

InspireMD Enrolls First Patient in the MASTER (MGuard for Acute ST Elevation Reperfusion) Randomized Trial

July 26, 2011

News Industry News

Enrollment at St. John's Hospital Marks Official Start of the Largest Randomized Peripheral Drug-Coated Balloon Trial To Date

July 25, 2011

News Daily News

ISAR-TEST 5 Published: Polymer-Free Dual DES Noninferior to Resolute

Jason Kahn

July 21, 2011

News Industry News

CID SpA announces the CE mark of its new Cre8™ Polymer-Free DES

July 19, 2011

News Industry News

OrbusNeich's GenousTM Stent Enables Early and Safe Discontinuation of Dual Antiplatelet Therapy in High-Risk Patients Requiring Nondeferrable, Non-Cardiac Surgery

July 18, 2011

News Daily News

DES Show Advantage over BMS for Heart Transplant Complication

L.A. McKeown

July 01, 2011

News Industry News

Micell Technologies Announces Reduced Clinical Trial Sample Size for MiStent® Drug-Eluting Coronary Stent Based on Early Clinical Data

June 29, 2011

News Industry News

Sahajanand Medical Technologies, India Receives CE Mark on Two Sirolimus Eluting Coronary Stents

June 26, 2011

News Daily News

Study Takes Clopidogrel into Account in Assessing DES Cost-Effectiveness

Caitlin E. Cox

June 24, 2011

News Industry News

Cordis Announces Discontinuation of NEVO Sirolimus-Eluting Coronary Stent

June 15, 2011

Advertisement

Landmark Analyses Show Downside of Prolonged Antiplatelet Therapy

Long-term Antiplatelet Therapy: All Risk, No Benefit

New-Generation DES Reduce Restenosis, Stent Thrombosis

TRIAS HR Published: Genous Stent Doubles Target Lesion Failure

First Patient in Japan Treated with Abbott's Bioresorbable Vascular Scaffold as Part of Global Clinical Trial

Selective Use of DES Saves Millions of Dollars a Year

Angioplasty May Be Alternative to Surgery for Common Femoral Artery Disease

Micell Technologies Completes Enrollment in DESSOLVE II Study of the MiStent® Drug-Eluting Coronary Stent

Medtronic Resolute® Drug-Eluting Stent Shows Superiority to Taxus® DES in Study of Patients with Coronary Artery Disease

InspireMD Enrolls First Patient in the MASTER (MGuard for Acute ST Elevation Reperfusion) Randomized Trial

InspireMD Enrolls First Patient in the MASTER (MGuard for Acute ST Elevation Reperfusion) Randomized Trial

Enrollment at St. John's Hospital Marks Official Start of the Largest Randomized Peripheral Drug-Coated Balloon Trial To Date

ISAR-TEST 5 Published: Polymer-Free Dual DES Noninferior to Resolute

CID SpA announces the CE mark of its new Cre8™ Polymer-Free DES

OrbusNeich's GenousTM Stent Enables Early and Safe Discontinuation of Dual Antiplatelet Therapy in High-Risk Patients Requiring Nondeferrable, Non-Cardiac Surgery

DES Show Advantage over BMS for Heart Transplant Complication

Micell Technologies Announces Reduced Clinical Trial Sample Size for MiStent® Drug-Eluting Coronary Stent Based on Early Clinical Data

Sahajanand Medical Technologies, India Receives CE Mark on Two Sirolimus Eluting Coronary Stents

Study Takes Clopidogrel into Account in Assessing DES Cost-Effectiveness

Cordis Announces Discontinuation of NEVO Sirolimus-Eluting Coronary Stent

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content